|
Diamond BioPharm Ltd |
 |
 |
|
Diamond Biopharm is one of very few European regulatory companies which has experience in clinical and regulatory development programmes within the gene therapy sector, to an advanced stage of development. Its first European Marketing Authorisation Application submission for a gene therapy product will be in 2009.
The company was founded in 2005, by Maureen Graham. Formerly Director of European Regulatory Affairs at Amgen, Maureen has a huge amount of experience in the biotechnology field and was later engaged (as Diamond BioPharm Limited) to lead the regulatory development of a pioneering gene therapy treatment. Supported by an experienced team of regulatory experts, Diamond is now a leader in this field.
|
|
Read more...
|
|
|
|
|
|
|
Page 1 of 2 |
